Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 17, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

放射治疗与单剂量卡博普拉丁在I期精子瘤的辅助治疗中:一项随机试验.

R T D Oliver1, M D Mason, G M Mead

  • 1Department of Medical Oncology, St Bart's and the London Hospital, London EC1A 7BE, UK. r.t.oliver@qmul.ac.uk

Lancet (London, England)
|July 26, 2005
PubMed
概括

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

ESMO open·2021
Same author

BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.

Journal of mammary gland biology and neoplasia·2019
Same author

The management of high-risk gestational trophoblastic tumours (GTT).

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I study.

Investigational new drugs·2017
Same author

A Report on the 2nd International Congress on Malaria, Held at Algiers, 19th to 27th May, 1930.

The Indian medical gazette·2017

卡博普拉丁化疗在I阶段精子瘤治疗中与放射治疗一样有效,二次癌症较少. 这项研究表明,卡博普拉丁可能是半瘤患者的首选选择.

科学领域:

  • 在瘤学瘤学.
  • 辐射瘤学 辐射瘤学
  • 医学瘤学 医学瘤学

背景情况:

  • 辅助放射治疗是I阶段精子瘤的标准治疗方法.
  • 放射治疗带有晚期非生殖细胞癌症和心血管事件的风险.
  • 最初的研究表明,单次注射碳烯化疗具有前途.

研究的目的:

  • 为了比较放射治疗与卡博普拉丁化疗对I阶段精子瘤的疗效和安全性.
  • 为了确定卡博普拉丁是否与放射治疗在预防复发方面不劣.

主要方法:

  • 一项大型随机试验,涉及1477名患者,遍及14个国家的70家医院 (1996-2001).
  • 患者被分配接受放射治疗 (n=904) 或一次碳烯注射 (n=573).
  • 主要结局是无复发率,该试验在2年后能够检测出3%的绝对差异.

主要成果:

  • 无复发的生存率在放射治疗和碳酸组在2年和3年之间是相似的.
  • 卡博普拉丁接受者报告说,他们的惰程度较低,缺勤次数也较少.
  • 在卡博普拉丁组 (p=0.04) 中观察到的第二次主要丸生殖细胞瘤较少 (p=0.04).

结论:

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

相关实验视频

Last Updated: Jul 17, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

  • 卡博普拉丁在I阶段的半瘤治疗中不劣于放射治疗.
  • 卡博普拉丁可能由于二次癌症的减少和患者福祉的改善而带来优势.
  • 需要长期的随访来证实这些发现.